Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Anziano

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|October 28, 2020
Model Informed Drug Development: Collaboration Through A Common FrameworkRichard J Anziano, Peter A Milligan
Contemporary Clinical Trials|July 15, 2014
Perspectives on clinical trial data transparency and disclosureDemissie Alemayehu, Richard J Anziano, Marcia Levenstein
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2014
Development of a straightforward and sensitive scale for MCI and early AD clinical trialsYifan Huang, Kaori Ito, Clare B Billing, et al.
Clinical Therapeutics|April 20, 2010
Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorderJeffrey J Miceli, Thomas G Tensfeldt, Thomas Shiovitz, et al.
Journal of Clinical Psychopharmacology|March 23, 2002
The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgeryKeith D Wilner, Richard J Anziano, Arlene C Johnson, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|October 28, 2020
Model Informed Drug Development: Collaboration Through A Common FrameworkRichard J Anziano, Peter A Milligan
Contemporary Clinical Trials|July 15, 2014
Perspectives on clinical trial data transparency and disclosureDemissie Alemayehu, Richard J Anziano, Marcia Levenstein
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2014
Development of a straightforward and sensitive scale for MCI and early AD clinical trialsYifan Huang, Kaori Ito, Clare B Billing, et al.
Clinical Therapeutics|April 20, 2010
Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorderJeffrey J Miceli, Thomas G Tensfeldt, Thomas Shiovitz, et al.
Journal of Clinical Psychopharmacology|March 23, 2002
The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgeryKeith D Wilner, Richard J Anziano, Arlene C Johnson, et al.
Pageof 1